Novel treatment regimen shows promise for diabetic macular edema

MedicalXpress | يون 22, 2026

For patients with diabetic macular edema (DME), intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection followed by a dexamethasone (DEX) intravitreal implant demonstrates noninferior efficacy and comparable safety to a conventional treatment regimen, according to a study published in the June issue of Eye Discovery.